The Health Care Select Sector SPDR® Fund ETF (NYSEARCA:XLV), which tracks the health care sector, and holds a weightage of 12 ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

This was the stock's second consecutive day of gains.

Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

Rashad Burgess is the Executive Director for HIV Community Operations at Gilead Sciences. He spoke with Kayla Thompson about importance of screening, health, and more!

MRK's regulatory filing for once-daily HIV pill DOR/ISL gets FDA acceptance, with a decision expected by April 2026.

U.S. stocks are mostly lower in afternoon trading Friday, pulling the market back from all-time highs, as the Trump ...